| Literature DB >> 25685074 |
Ali H Mokdad1, Katherine Ellicott Colson2, Paola Zúñiga-Brenes3, Diego Ríos-Zertuche3, Erin B Palmisano2, Eyleen Alfaro-Porras4, Brent W Anderson5, Marco Borgo6, Sima Desai2, Marielle C Gagnier2, Catherine W Gillespie7, Sandra L Giron8, Annie Haakenstad2, Sonia López Romero6, Julio Mateus8, Abigail McKay9, Ali A Mokdad10, Tasha Murphy11, Paria Naghavi2, Jennifer Nelson3, Miguel Orozco12, Dharani Ranganathan13, Benito Salvatierra14, Alexandra Schaefer2, Gulnoza Usmanova2, Alejandro Varela8, Shelley Wilson2, Sarah Wulf2, Bernardo Hernandez2, Rafael Lozano2, Emma Iriarte3, Ferdinando Regalia15.
Abstract
BACKGROUND: Health has improved markedly in Mesoamerica, the region consisting of southern Mexico and Central America, over the past decade. Despite this progress, there remain substantial inequalities in health outcomes, access, and quality of medical care between and within countries. Poor, indigenous, and rural populations have considerably worse health indicators than national or regional averages. In an effort to address these health inequalities, the Salud Mesoamérica 2015 Initiative (SM2015), a results-based financing initiative, was established.Entities:
Keywords: Anemia; Antenatal care; Contraceptives; Health facilities; Results-based financing; Salud Mesoamerica 2015; Skilled birth attendance; Vaccination; Wasting
Year: 2015 PMID: 25685074 PMCID: PMC4327957 DOI: 10.1186/s12963-015-0034-4
Source DB: PubMed Journal: Popul Health Metr ISSN: 1478-7954
Figure 1Data collection timeline.
Sample description by country
|
|
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| |
| Belize** | 351 | 311 | 39 | ||||||||
| Costa Rica*** | 924 | ||||||||||
| El Salvador | 16,178 | 3,625 | 4,730 | 3,328 | 65 | ||||||
| Guatemala | 16,847 | 3,604 | 3,546 | 874 | 4,658 | 1,241 | 4,224 | 1,058 | 64 | 29 | |
| Honduras | 8,132 | 7,609 | 1,526 | 1,445 | 1,868 | 1,474 | 1,622 | 1,522 | 59 | 31 | |
| Mexico | 17,471 | 6,878 | 3,877 | 1,551 | 5,016 | 1, 972 | 4,635 | 1,827 | 60 | 30 | |
| Nicaragua | 5,698 | 3,169 | 1,300 | 771 | 1,720 | 1,103 | 1,407 | 818 | 40 | 24 | |
| Panama | 4,947 | 1,710 | 2,453 | 2,253 | 38 | ||||||
| Total | 69273 | 21260 | 15584 | 4641 | 20796 | 3818 | 17780 | 5225 | 365 | 114 | 924 |
*Reflects total number of occupied households counted by the SM2015 Census (90,533). Of these, 88,546 completed the census questionnaire.
**Convenience community survey.
***Surveys conducted in 41 schools capturing responses from 365 boys and 555 girls in grades 7 to 11.
Health facility sample by EONC classification
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Belize | 35 | 2 | 2 | |||
| El Salvador | 58 | 7 | ||||
| Guatemala | 47 | 21 | 13 | 7 | 4 | 1 |
| Honduras | 45 | 20 | 8 | 7 | 6 | 4 |
| Mexico | 41 | 19 | 11 | 7 | 8 | 4 |
| Nicaragua | 32 | 23 | 5 | 1 | 3 | |
| Panama | 21 | 17 | ||||
| Total | 279 | 83 | 63 | 22 | 23 | 9 |
EONC: essential obstetric and neonatal care.
Distribution of weight by height z-score by country
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| less than −3 | 0% | 0% | 0% | 0% | 0% | 0% |
| −3 to −2 | 1% | 0% | 1% | 0% | 1% | 0% |
| −2 to 0 | 39% | 1% | 40% | 1% | 30% | 1% |
| 0 to 2 | 54% | 1% | 54% | 1% | 62% | 1% |
| 2 to 3 | 3% | 0% | 4% | 0% | 5% | 0% |
| greater than 3 | 2% | 0% | 2% | 0% | 2% | 0% |
|
|
|
|
| |||
|
|
|
|
|
|
| |
| less than −3 | 0% | 0% | 1% | 0% | 1% | 0% |
| −3 to −2 | 1% | 0% | 1% | 0% | 2% | 0% |
| −2 to 0 | 35% | 1% | 42% | 2% | 41% | 1% |
| 0 to 2 | 57% | 1% | 53% | 2% | 51% | 1% |
| 2 to 3 | 5% | 1% | 2% | 0% | 4% | 0% |
| greater than 3 | 3% | 1% | 1% | 0% | 2% | 0% |
Figure 2Anemia prevalence by age and country.
Figure 3Antenatal and delivery care indicators by country.
Figure 4Rating of overall quality of care for the most recent health facility visit, by country.
Self-reported sexual activity and contraceptive among students in Costa Rica, by grade
|
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |||
|
| Both | 236 | 22 | 5 | 2 | 15 | 73 | 11 | 21 | 98 | 2 |
| Female | 126 | 16 | 6 | 3 | 11 | 81 | 9 | 15 | 97 | 3 | |
| Male | 110 | 6 | 3 | 2 | 4 | 53 | 27 | 6 | 100 | 0 | |
|
| Both | 217 | 41 | 12 | 4 | 22 | 51 | 11 | 34 | 82 | 8 |
| Female | 127 | 24 | 16 | 6 | 8 | 30 | 16 | 18 | 72 | 15 | |
| Male | 88 | 16 | 8 | 4 | 14 | 93 | 4 | 15 | 98 | 2 | |
|
| Both | 214 | 43 | 27 | 7 | 31 | 69 | 16 | 38 | 96 | 2 |
| Female | 140 | 28 | 28 | 10 | 17 | 57 | 21 | 23 | 94 | 4 | |
| Male | 72 | 14 | 26 | 9 | 14 | 100 | - | 14 | 100 | 0 | |
|
| Both | 202 | 46 | 21 | 4 | 32 | 75 | 6 | 37 | 81 | 7 |
| Female | 131 | 27 | 22 | 6 | 16 | 70 | 7 | 20 | 77 | 8 | |
| Male | 71 | 19 | 20 | 7 | 16 | 86 | 10 | 17 | 90 | 10 | |
|
| Both | 42 | 10 | 41 | 8 | 8 | 83 | 15 | 8 | 83 | 15 |
| Female | 22 | 3 | 9 | 7 | 3 | 100 | - | 3 | 100 | - | |
| Male | 20 | 7 | 71 | 18 | 5 | 80 | 18 | 5 | 80 | 18 | |
*Effective sample size of sexually active students may be smaller due to exclusion of observations with missing data on contraceptive use.
Availability and stock-out of contraceptives in health facilities that reported storing contraceptives
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
| Belize | 19 | 89.5 | 100 | 78.9 | 36.8 | 15 | 0.0 | 6.7 | 33.3 |
| El Salvador | 65 | 90.8 | 87.7 | 90.8 | 21.5 | *** | *** | *** | *** |
| Guatemala | 90 | 88.9 | 78.9 | 97.8 | 24.4 | 61 | 1.6 | 9.8 | 9.8 |
| Honduras | 89 | 96.6 | 94.4 | 94.4 | 70.8 | 79 | 0.0 | 5.1 | 2.5**** |
| Mexico | 73 | 93.2 | 87.7 | 86.3 | 58.9 | 40 | 5.0 | 17.5 | 20.0 |
| Nicaragua | 63 | 82.5 | 85.7 | 98.4 | 76.9 | 46 | 4.3 | 4.3 | 13.0 |
| Panama | 24 | 100 | 75.0 | 75.0 | 37.5 | 9 | 0.0 | 0.0 | 22.2 |
*Among facilities that reported routinely storing contraceptives.
**Stock-out of contraceptives in the three months prior to the day of the survey. These questions were only asked at ambulatory EONC facilities with availability of male condoms, oral contraceptives, and injectable contraceptives on the day of the survey and basic and complete EONC facilities with availability of male condoms, oral contraceptives, injectable contraceptives, and IUD on the day of the survey. Stock-outs not captured for IUD.
***Stock-outs not captured in El Salvador.
****Due to missing data points, 75 facilities asked about previous months’ stock of injectables instead of 79 facilities.
Availability and stock-out of vaccines in health facilities that reported routinely storing vaccines
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
| Belize | 10 | 100 | 100 | 100 | *** | *** | 9 | 0.0 | 0.0 |
| El Salvador | 28 | 78.6 | 76.9 | 96.4 | 71.4 | 75.0 | *** | **** | **** |
| Guatemala | 55 | 96.4 | 96.4 | 96.4 | 92.7 | 90.9 | 33 | 3.0 | 3.0 |
| Honduras | 84 | 86.9 | 77.4 | 78.6 | 76.2 | 75.0 | 9 | 22.2 | 11.1 |
| Mexico | 37 | 73.0 | 83.8 | 78.4 | 40.5 | 78.4 | 7 | 42.9 | 57.1 |
| Nicaragua | 41 | 31.7 | 95.1 | 97.6 | 65.9 | 92.7 | 1 | 0.0 | 0.0 |
| Panama | 14 | 100 | 92.9 | 100 | 100 | 100 | 11 | 9.1 | 9.1 |
*Among facilities that reported routinely storing vaccines.
**Stock-out of vaccines in the three months prior to the day of the survey, not including availability on the day of the survey. These questions were only asked of facilities with all vaccines in stock on the day of the survey.
***Pneumonia and Rotavirus vaccines not measured in Belize.
****Stock-outs not captured for El Salvador. Influenza and Polio vaccines were observed but not included in analysis due to the fact that these vaccines are only administered at certain times of the year and therefore are not always expected to be in stock at facilities that routinely store other vaccines.
Comparison of selected indicators to national estimates
|
|
|
|
|
|
|---|---|---|---|---|
| 1 skilled antenatal care visit, all births in the past 2 years | Belize | 98% | 94% | 4% |
| Institutional delivery, all births in the past 2 years | Belize | 99% | 88% | 11% |
| MMR immunization† | Belize | 87% | 82% | 5% |
| Full immunization† | Belize | 68% | 56% | 12% |
| Exclusive breastfeeding, children aged 0–5 months | Belize | 33% | 10% | 23% |
| Oral rehydration therapy | Belize | 73% | 61% | 13% |
| Unmet need for contraception | Belize | 28% | 31% | −4% |
| 1 skilled antenatal care visit, all births in the past 5 years | Nicaragua | 94% | 95% | −1% |
| 4 skilled antenatal care visits, all births in the past 5 years | Nicaragua | 80% | 93% | −14% |
| Institutional delivery, all births in the past 5 years | Nicaragua | 87% | 88% | −1% |
| Measles immunization for children aged 12–29 months† | Nicaragua | 88% | 88% | 0% |
| 1 or more antenatal care visits for the most recent pregnancy in the past 5 years, among women 20–49 years old | Mexico | 94% | 99% | −5% |
| Anemia, children aged 12–59 months | Mexico | 25% | 24% | 0% |
| MMR immunization, children aged 12–23 months, according to health card only | Mexico | 49% | 81% | −32% |
| Wasting (<−2SD weight for height) | Mexico | 1% | 2% | 0% |
| Unmet need for contraception | Panama | 88% | 27% | 61% |
| 1 skilled antenatal care visit, all births in the past 5 years | Panama | 75% | 96% | −21% |
| Institutional delivery, all births in the past 5 years | Panama | 79% | 88% | −10% |
| Exclusive breastfeeding, children 0–5 months | Panama | 45% | 28% | 17% |
| Anemia, 6–59 months | Honduras | 26% | 29% | −4% |
| MMR coverage for children aged 12–23 months† | Honduras | 94% | 88% | 6% |
| Contraceptive prevalence, modern methods | Honduras | 70% | 64% | 6% |
| 1 skilled antenatal care visit, for most recent birth in the past 5 years | Honduras | 79% | 97% | −18% |
| Breastfeeding initiated within an hour of birth, most recent birth in past 5 years | Honduras | 74% | 64% | 10% |
| Contraceptive prevalence, any method | El Salvador | 33% | 73% | −40% |
| 1 antenatal care visit, any attendant, all births in last 5 years | El Salvador | 98% | 94% | 4% |
| Timely initiation of breastfeeding, all births in last 5 years | El Salvador | 67% | 33% | 34% |
| Exclusive breastfeeding, children aged 0–5 months | El Salvador | 60% | 31% | 29% |
| Stunting | El Salvador | 16% | 19% | −3% |
| Anemia, children aged 12–59 months | El Salvador | 25% | 23% | 2% |
| Oral rehydration therapy | El Salvador | 64% | 51% | 13% |
| Condom use at last sexual intercourse, women aged 15-19 | Costa Rica | 64% | 44% | 20% |
| Measles immunization**† | Guatemala | 88% | 76% | 13% |
| DPT immunization**† | Guatemala | 87% | 83% | 4% |
| 1 antenatal care visit, any attendant, most recent birth in last 5 years | Guatemala | s80% | 83% | −3% |
| Skilled birth attendance, most recent birth in last 5 years | Guatemala | 23% | 54% | −32% |
| Institutional delivery, most recent birth in last 5 years | Guatemala | 23% | 53% | −31% |
*Sourcesnn Belize: 2006 Multiple Indicator Cluster Survey (MICS). Guatemala: 2006 Encuesta de condiciones de vida (ENCOVI). Honduras: 2011–2012 Demographic and Health Survey (DHS/ENDESA). Mexico: 2011–2012 National Health and Nutrition Survey (ENSANUT). Panama: 2009 National Survey of Sexual and Reproductive Health (ENASSER). El Salvador: 2008 Reproductive Health Survey (RHS/FESAL).
**National estimate for children under 6 years.
†Based on vaccine card and caregiver recall.
Child indicators include aged 0–59 months unless otherwise noted.